01501.HK
Shanghai Kindly Medical Instruments Co., Ltd.
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 34.40
−3.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.1B | 1.1B | 852.0M | 752.8M | 585.9M |
| Cost of Revenue | 825.9M | 428.7M | 314.3M | 314.8M | 253.4M |
| Gross Profit | 1.3B | 636.8M | 537.7M | 438.1M | 332.5M |
| Operating Expenses | |||||
| R&D Expense | 300.1M | 150.1M | 149.1M | 125.8M | 99.6M |
| SG&A Expense | 538.1M | 265.8M | 199.6M | 166.8M | 120.7M |
| General & Admin Expense | 214.9M | 149.3M | 120.8M | 99.4M | 64.3M |
| Selling & Marketing Expense | 162.5M | 116.8M | 79.4M | 67.4M | 56.4M |
| Other Expenses | (53.9M) | (50.6M) | (27.3M) | (32.9M) | (33.1M) |
| Total Operating Expenses | 784.3M | 365.3M | 321.5M | 259.7M | 187.2M |
| Cost and Expenses | 1.6B | 794.0M | 635.7M | 574.5M | 440.6M |
| Operating Income (EBIT) | 502.7M | 271.5M | 216.2M | 178.3M | 145.3M |
| Non-Operating | |||||
| Interest Income | 30.7M | 12.0M | 9.1M | 11.8M | 13.4M |
| Interest Expense | 18.2M | 12.5M | 2.4M | 3.2M | 818.0K |
| Net Interest Income | 12.5M | (554.0K) | 6.7M | 8.6M | 12.6M |
| Other Non-Op Income/Expense | 955.8K | (13.1M) | (2.8M) | (3.2M) | (818.0K) |
| Non-Operating Income (excl Interest) | 2.3M | 13.2M | 3.6M | 16.3M | 15.9M |
| EBT (Pre-Tax Income) | 503.6M | 258.3M | 213.4M | 175.1M | 144.5M |
| Income Tax Expense | 56.2M | 25.6M | 23.3M | 21.9M | 10.6M |
| Bottom Line | |||||
| Net Income | 419.0M | 218.8M | 191.9M | 156.5M | 131.7M |
| Earnings from Cont. Ops | 447.5M | 232.7M | 190.0M | 153.2M | 133.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 400.1M | 206.2M | 180.9M | 151.9M | 131.7M |
| Per Share | |||||
| Basic EPS | HK$2.24 | HK$1.26 | HK$1.06 | HK$0.89 | HK$0.79 |
| Diluted EPS | HK$2.24 | HK$1.26 | HK$1.06 | HK$0.89 | HK$0.78 |
| Revenue Per Share | HK$10.88 | HK$6.19 | HK$4.99 | HK$4.41 | HK$3.50 |
| Shares | |||||
| Basic Shares Outstanding | 194.2M | 172.3M | 170.7M | 170.9M | 167.3M |
| Diluted Shares Outstanding | 202.2M | 172.3M | 170.7M | 170.9M | 168.4M |
| Profitability Metrics | |||||
| EBITDA | 655.4M | 353.1M | 255.4M | 225.9M | 160.0M |
| D&A | 155.0M | 94.8M | 42.8M | 47.6M | 30.6M |
| EBIT | 500.4M | 258.3M | 212.6M | 178.3M | 129.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026